8 Coupons
-
Special Offer
-
30% off
david dodick, md, neurologist, mayo clinic; chairman, american migraine foundation. .
. media won�t investigate medically-caused death numbers
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
senator: sir, i have the numbers in front of me. how can you keep this secret from the public? . .
.
.